The Klinique Medical Clinic PCL (BKK:KLINIQ) ROCE %: 27.41% (As of Mar. 2026)


BKK:KLINIQ The Klinique Medical Clinic PCL BKK:KLINIQ
88 GF Score
Price ฿25.75
GF Value ฿44.60
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is The Klinique Medical Clinic PCL ROCE %?

The Klinique Medical Clinic PCL BKK:KLINIQ 88 ROCE % is 27.41% as of Mar. 2026. GuruFocus rates BKK:KLINIQ with a GF Score™ of 88/100 and a GF Value™ of ฿44.60 (Significantly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. The Klinique Medical Clinic PCL's annualized ROCE % for the quarter that ended in Mar. 2026 was 27.41%.


The Klinique Medical Clinic PCL  (BKK:KLINIQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


The Klinique Medical Clinic PCL ROCE % Related Terms


The Klinique Medical Clinic PCL ROCE % Historical Data

* Premium members only.

The historical data trend for The Klinique Medical Clinic PCL's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Klinique Medical Clinic PCL ROCE % Chart

The Klinique Medical Clinic PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 51.53 23.35 18.43 19.15 21.32

The Klinique Medical Clinic PCL Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.65 20.86 19.02 26.15 27.41
BKK:KLINIQ
88GF Score
The Klinique Medical Clinic PCL BKK:KLINIQ
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Klinique Medical Clinic PCL ROCE % Calculation

The Klinique Medical Clinic PCL's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=487.383/( ( (3118.143 - 864.983) + (3339.264 - 1020.308) )/ 2 )
=487.383/( (2253.16+2318.956)/ 2 )
=487.383/2286.058
=21.32 %

The Klinique Medical Clinic PCL's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=647.708/( ( (3339.264 - 1020.308) + (3548.512 - 1141.975) )/ 2 )
=647.708/( ( 2318.956 + 2406.537 )/ 2 )
=647.708/2362.7465
=27.41 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 27.41% mean?
The Klinique Medical Clinic PCL (BKK:KLINIQ) has a ROCE % of 27.41% as of Mar. 2026.
Is The Klinique Medical Clinic PCL's ROCE % too high?
The Klinique Medical Clinic PCL's current ROCE % is 27.41%. The Personal Services industry median ROCE % is 6.08. The Klinique Medical Clinic PCL's value of 27.41% is 350.8% above this industry median. Overall, The Klinique Medical Clinic PCL has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Klinique Medical Clinic PCL's ROCE % compare to ROL and SCI?
The Klinique Medical Clinic PCL's ROCE % of 27.41% can be compared against companies in the Personal Services industry. The industry median ROCE % is 6.08. The Klinique Medical Clinic PCL's value of 27.41% is 350.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Personal Services company?
The median ROCE % among Personal Services companies is 6.08, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Klinique Medical Clinic PCL's current ROCE % of 27.41% is 350.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Personal Services industry, the median ROCE % is 6.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Klinique Medical Clinic PCL's current ROCE % is 27.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Klinique Medical Clinic PCL stock overvalued right now?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL (BKK:KLINIQ) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿44.60, compared to a current price of ฿25.75 — trading 42.3% below its estimated fair value. The current ROCE % is 27.41% and 350.8% above the Personal Services industry median of 6.08. The Klinique Medical Clinic PCL's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For The Klinique Medical Clinic PCL (BKK:KLINIQ), the current ROCE % is 27.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Klinique Medical Clinic PCL (BKK:KLINIQ) Overvalued in 2026?

Based on GuruFocus' analysis, The Klinique Medical Clinic PCL stock appears to be undervalued. The current stock price of ฿25.75 is trading 42.3% below its estimated GF Value™ of ฿44.60. GuruFocus considers The Klinique Medical Clinic PCL to be Significantly Undervalued.

Key valuation signals for BKK:KLINIQ:

  • ROCE %: 27.41%
  • GF Value™: ฿44.60 vs. price of ฿25.75 (42.3% below fair value)
  • GF Score™: 88/100 with 4 warning signs
  • Industry Position: 350.8% above the Personal Services median

No single metric tells the full story. See the BKK:KLINIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


The Klinique Medical Clinic PCL Business Description

Address New Petchburi Road, 2922/296-299, Charn Issara Tower 2, 27th Floor, Bangkapi, Huay Kwang, Bangkok, THA, 10310
The Klinique Medical Clinic PCL provides skin care services, beauty, skin care, body contouring, and surgery. including providing holistic care services. The company has a wide range of services and products to meet the needs of customers at all levels, such as facial treatment services, reducing redness, reducing dark spots, laser services for face lifting, face reshaping, skin care, Body shape by removing and dissolving fat, cosmetic surgery, etc. In addition, the company also sells cosmeceuticals. There are various types of products, such as Special Care, Clean & Prepare, Whitening Set, Sun Care, and Antioxidant. The group operates two core business segments: Skin medical services and distribution of cosmetics and medical cosmetics; and Surgery services.
88GF Score

Get the complete analysis for BKK:KLINIQ

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿25.75
Price
฿44.60
GF Value